title: EORTC-IDBBC (Investigational Drug Branch for Breast Cancer): 5 years of European collaboration in new drug development for breast cancer.
authors.affiliation: Jules Bordet Institute, Chemotherapy Unit, Brussels, Belgium.
authors.forename: A
authors.initials: A
authors.lastname: Awada
authors.forename: A
authors.initials: A
authors.lastname: Van Vreckem
authors.forename: R
authors.initials: R
authors.lastname: Paridaens
authors.forename: P F
authors.initials: PF
authors.lastname: Bruning
authors.forename: J
authors.initials: J
authors.lastname: Klijn
authors.forename: E
authors.initials: E
authors.lastname: Tomiak
authors.forename: J
authors.initials: J
authors.lastname: Vinholes
authors.forename: J A
authors.initials: JA
authors.lastname: Roy
authors.forename: Z
authors.initials: Z
authors.lastname: Kusenda
authors.forename: G
authors.initials: G
authors.lastname: Hoctin Boes
authors.forename: M
authors.initials: M
authors.lastname: Van Glabbeke
authors.forename: M J
authors.initials: MJ
authors.lastname: Piccart
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D015507:Drugs, Investigational / Q000627:therapeutic use; D005060:Europe; D005260:Female; D006801:Humans; D007391:International Cooperation; D009362:Neoplasm Metastasis
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational